Argus Biosciences LLC Company Profile

15:09 EDT 24th September 2018 | BioPortfolio

Argus Biosciences was founded in 2003 by Dr. David Whyte.Dr. Whyte received his Ph.D. in Molecular Biology from the University of California, San Francisco, and has a Bachelors of Science degree in Chemistry from the University of Michigan, Ann Arbor.After receiving his doctorate, Dr. Whyte worked as a Principal Scientist at the Schering Plough Research Institute in Kenilworth, New Jersey, and as Director of Molecular Technologies at SUGEN, South San Francisco, California.
Our focus is personalized DNA sequence analysis.In addition to offering sequence analysis of medically significant genes, we have recently added a suite of products in the area of molecular genealogy.


2033 Ralston Ave, #84
United States of America


Phone: 650-954-1055

News Articles [698 Associated News Articles listed on BioPortfolio]

Apple-Aktie: Erwartungen könnten übertroffen werden!

New York ( - Apple-Aktienanalyse von Analyst Jim Kelleher von Argus Research: Aktienanalyst Jim Kelleher vom Investmenthaus Argus Research empfiehlt die Aktien von Apple Inc. (IS...

Cardinal Health (CAH) Stock Rating Upgraded by Argus

The firm presently has a $85.00 target price on the stock. Argus' target price indicates a potential upside of 38.71% from the company's current price.

Celgene-Aktie: Furcht vor größerer Volatilität!

New York ( - Celgene-Aktienanalyse von Analyst David Toung von Argus Research: David Toung, Aktienanalyst vom Investmenthaus Argus Research, empfiehlt im Rahmen einer Aktienanaly...

ASC Biosciences, Inc. announces ad dates for first television commercial

About ASC Biosciences, Inc.ASC Biosciences, Inc. ("ASC" or the "Company") is a development stage biotechnology company with a proprietary adult stem cell platform capable Read more...

Argus Radiology Announces Expansion of Their TeleRadiology Services into Georgia

Argus Radiology is a Joint Commission accredited, radiologist owned, TeleRadiology company offering a unique business model that assigns a limited number of Radiologists to each facility (usually 5-7)...

Strategic partnership forms between Taconic Biosciences and Cyagen Biosciences

A strategic partnership has been formed between Taconic Biosciences and Cyagen Biosciences — both global companies that generate custom genetically engineered rodent models and associated services.

SOLID BIOSCIENCES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Solid Biosciences Inc. to Contact The Firm

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Solid Biosciences Inc. ("Solid Biosciences" or th...

African Women for Biosciences Platform Launched

Women in biosciences remain grossly under represented in leadership and decision-making levels, limiting contribution of scientific research to national development. A new platform - the African Women...

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

PubMed Articles [74 Associated PubMed Articles listed on BioPortfolio]

Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients after Argus II Implantation: an International Study.

To assess the retinal anatomy and array position in the Argus II Retinal Prosthesis recipients.

Phoenixin participated in regulation of food intake and growth in spotted scat, Scatophagus argus.

Phoenixin (Pnx) is an endogenous peptide known to be involved in reproduction and food intake in rats, with two active isoforms, phoenixin-14 (Pnx-14) and phoenixin-20 (Pnx-20). However, little is kno...

Argus II Retinal Prosthesis Implantation Using Three-Dimensional Visualization System.


To report and describe the anatomical changes detected by spectral domain optical coherence tomography between an Argus II retinal prosthesis and the inner retinal layers during 1-year follow-up.

Clinical diagnostic suspicion: a key component to being a modern Argus in medicine!

Clinical Trials [16 Associated Clinical Trials listed on BioPortfolio]

New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System

This post-approval study is being implemented to monitor the use of Argus II System in a larger US population than available within pre-approval studies. An attempt will be made to includ...

Argus II Retinal Prosthesis System - Better Vision RP Study

The study is conducted to evaluate the safety and benefit of the Argus II System in a selected patient population with advanced Retinitis Pigmentosa who have a measurable central residual ...

Argus™ II Retinal Stimulation System Feasibility Protocol

The objective of this feasibility study is to evaluate the safety and utility of the Argus II Retinal Stimulation System in providing visual function to blind subjects with severe to profo...

Self-confidence Study in Patients With Argus II Artificial Retina

To evaluate whether the use of the Argus II retinal prosthesis improves the confidence and self-esteem of patients with advanced retinopathy pigmentosa

CAREN Argus Rehab (CARE) Study

The goal of the current project is to fill the unmet clinical needs around the objective assessment of visual function and develop outcome-oriented visual rehabilitation approach using the...

Companies [377 Associated Companies listed on BioPortfolio]

Argus Biosciences LLC

Argus Biosciences was founded in 2003 by Dr. David Whyte.Dr. Whyte received his Ph.D. in Molecular Biology from the University of California, San Francisco, and has a Bachelors of Science degree in Ch...

Argus Dental Plan

Founded in 2007 by a Florida dentist, Argus Dental Plan provides dental benefits that offer value and quality to all members. Argus is licensed through the Florida Department of I...

Argus Health Systems, Inc.

Argus is the leading independent provider of health care information management services supporting commercial, Medicare Part D, and Medicaid through a fully transparent business model. Argus is a who...

Argus Media

Argus is a leading provider of price assessments, business intelligence and market data on the global crude and products, natural gas, coal, electricity, emissions and transportation industries. It is...

Argus Dental & Vision, Inc.

Founded in 2007 by a Florida dentist, Argus Dental & Vision provides dental and vision benefits that offer value and quality to members. Argus is licensed through the Florida Depa...

More Information about "Argus Biosciences LLC" on BioPortfolio

We have published hundreds of Argus Biosciences LLC news stories on BioPortfolio along with dozens of Argus Biosciences LLC Clinical Trials and PubMed Articles about Argus Biosciences LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Argus Biosciences LLC Companies in our database. You can also find out about relevant Argus Biosciences LLC Drugs and Medications on this site too.

Quick Search


Relevant Topic

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Corporate Database Quicklinks

Searches Linking to this Company Record